Bamiphylline improves exercise-induced myocardial ischemia through a novel mechanism of action. | Zendy

Achille Gaspardone | Zendy; Filippo Crea | Zendy; Maria Iamele | Zendy; Fabrizio Tomai | Zendy; Francesco Versaci | Zendy; Antonio Pellegrino | Zendy; Luigi Chiariello | Zendy; Pier Agostino Gioffrè | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Bamiphylline improves exercise-induced myocardial ischemia through a novel mechanism of action.

Author(s) -

Achille Gaspardone,

Filippo Crea,

Maria Iamele,

Fabrizio Tomai,

Francesco Versaci,

Antonio Pellegrino,

Luigi Chiariello,

Pier Agostino Gioffrè

Publication year - 1993

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.88.2.502

Subject(s) - medicine , aminophylline , cardiology , heart rate , ejection fraction , angina , placebo , rate pressure product , anesthesia , blood pressure , supine position , adenosine , ischemia , myocardial infarction , heart failure , alternative medicine , pathology

In patients with stable angina pectoris aminophylline, a nonselective antagonist of adenosine receptors, markedly improves exercise capacity. To establish the role played by A1 adenosine receptors in the anti-ischemic action of aminophylline, the effects of bamiphylline, a selective A1 antagonist, on exercise-induced ischemia were investigated in patients with stable angina pectoris.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research